Earnings History Data for Antibe Therapeutics (ATBPF) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Antibe Therapeutics
Antibe Therapeutics Inc. is a biotech company with a drug platform of therapeutics in pain and inflammation. Its lead drug candidate consists of ATB-346, non-addictive drug for chronic pain and inflammation; ATB-352, for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin. Antibe Therapeutics Inc. is based in Toronto, Canada.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-02-2024 | PM | ATBPF | Antibe Therapeutics | 36.00 | -0.06 | -0.09 | 0.00 | Antibe Therapeutics Non-GAAP EPS of -C$0.08 [2/14/2024 8:06 AM] |
0.6754 | 0.01 (0.81%) |
0.0 | 0.0 (0.00%) |
0.33 - 0.89 | 12,732 | 0 | 0 | ||
| 13-11-2023 | PM | ATBPF | Antibe Therapeutics | 33.00 | -0.07 | -0.09 | 0.00 | Antibe Therapeutics reports Q2 results [11/13/2023 11:01 AM] |
0.6630 | -0.04 (-5.19%) |
0.0 | 0.0 (0.00%) |
0.28 - 0.89 | 99,257 | 0 | 0 | ||
| 14-08-2023 | PM | ATBPF | Antibe Therapeutics | 20.00 | -0.08 | -0.08 | 0.00 | Antibe Therapeutics GAAP EPS of -C$0.11 [8/14/2023 2:10 PM] |
0.41 | -0.01 (-1.26%) |
0.0 | 0.0 (0.00%) |
0.28 - 0.54 | 9,000 | 0 | 0 | ||
| 29-06-2023 | PM | ATBPF | Antibe Therapeutics | 19.00 | -0.04 | -0.07 | 0.00 | 0.3546 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.28 - 0.54 | 1,550 | 0 | 0 | |||
|
|
||||||||||||||||||
| 15-08-2022 | PM | ATBPF | Antibe Therapeutics | 26.00 | -0.08 | -0.09 | 0.00 | Antibe Therapeutics Inc. GAAP EPS of -$0.10 misses by $0.02 [8/15/2022 8:27 AM] |
0.5020 | 0.0 (0.74%) |
0.0 | 0.0 (0.00%) |
0.42 - 1.11 | 9,501 | 0 | 0 | ||
| 14-02-2022 | PM | ATBPF | Antibe Therapeutics | 28.00 | -0.08 | -0.13 | 0.00 | Antibe Therapeutics GAAP EPS of -$0.09 [2/14/2022 7:32 AM] |
0.5376 | 0.02 (2.99%) |
0.0 | 0.0 (0.00%) |
0.44 - 5.88 | 3,277 | 0 | 0 | ||
| 16-11-2021 | PM | ATBPF | Antibe Therapeutics | 38.00 | -0.13 | -0.12 | 0.00 | Antibe Therapeutics reports FQ2 results [11/16/2021 8:00 AM] |
0.0 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 0 | 0 | 0 | ||
| 28-06-2021 | PM | ATBPF | Antibe Therapeutics Inc. | 156.00 | -0.11 | -0.05 | 0.00 | 0.0 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 0 | 0 | 0 | |||